Log in to search using one of your social media accounts:

 

Sialendoscopic Approach in Management of Juvenile Recurrent Parotitis

AbstractTo assess the role of sialendoscopy as a diagnostic and therapeutic modality in juvenile recurrent parotitis. Juvenile recurrent parotitis (JRP) is the second most frequent salivary gland disease in childhood and is characterized by recurrent non suppurative and non obstructive parotid inflammation. These attacks influence the quality of life and can even lead to gland destruction, and there are no definitive treatment to avoid them. Sialendoscopic dilatation is emerging as the new treatment modality in this aspect. Study design:  retrospective study. Study setting: Department of Otorhinolaryngology in tertiary care hospital. 17 cases of juvenile recurrent parotitis (i.e. children of age group 3–11 years presenting with complaints of recurrent parotid region swelling and pain, sometimes associated with fever) were includ ed in the study during October 2012–September 2015. All cases underwent sialendoscopy under general anaesthesia. Diagnostic (classifying the ductal lesion) and interventional sialendoscopic procedure (dilatation with instillation of steroid) were carried out in single sitting. Follow up was done f or a minimum of 6 months (range 6–36 months). 17 patients with mean age of 5.6 years and gender distribution of 47:53 (boys:girls) underwent sialendoscopy for JRP. 8 patients presented with unilateral parotitis and 9 with bilateral. The mean number of attacks in previous 1 year were 9.2. Avera ge time for proce...
Source: Indian Journal of Otolaryngology and Head and Neck Surgery - Category: ENT & OMF Source Type: research

Related Links:

ARTHRITIS pain affects about 10 million people in the UK. You can prevent symptoms by making small diet and lifestyle changes, including adding these five exercises to your workout plan.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Purpose of review Monoclonal antibodies (mAbs) targeting the calcitonin-gene-related peptide (CGRP) pathway have been developed for episodic and chronic migraine prevention, either through binding the CGRP ligand (eptinezumab, fremanezumab, galcanezumab) or the CGRP receptor (erenumab). We provide an update on published Phase 2 and Phase 3 trials, safety/tolerability data, pharmacokinetics and mechanism of action of these biologicals. Recent findings The efficacy data from Phase 2 trials are corroborated by those from published Phase 3 trials, with a multitude of publications expected in 2018. Review of safety data co...
Source: Current Opinion in Neurology - Category: Neurology Tags: HEADACHE: Edited by Peter Goadsby Source Type: research
Purpose of review The current article reviews recent data on treatment of acute headache patients in the acute care setting. Recent findings Intravenous fluid hydration, a common component of emergency department (ED) migraine therapy, does not improve pain outcomes and leads to longer ED lengths of stay. Therefore, intravenous fluids should be administered only to migraine patients with clinical evidence of dehydration. Similarly, intravenous ketamine has garnered interest as a treatment for acute pain but does not provide substantial relief to migraine patients. New studies on the serotonin (5-HT3; 5-hydroxytryptami...
Source: Current Opinion in Neurology - Category: Neurology Tags: HEADACHE: Edited by Peter Goadsby Source Type: research
Conclusions: The BI-RADS classification–based treatment algorithm may not be valid in adolescents. In the present study, all patients with lesions with BI-RADS ≥3 levels had revealed benign pathologies. The BI-RADS classification may show an increased risk. However, to determine the need for a biopsy in adolescents, there is a need for larger-scale pediatric and adolescent studies using the BI-RADS classification.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Original Articles Source Type: research
We thank Drs Gaballa and Moyer1 for their interest in  our recently published article.2 Their recommendation to use a standardized lexicon for adverse events (AEs) is of great value. The AE rate in our study was 8.3% (3/36). It was revealed that EUS-guided ablation with ethanol with or without paclitaxel injection was fairly safe, with an AE rate of 10% to 15%.3 The advantage of lauromacrogol seemed to be weak compared with ethanol in treatment safety. In our opinion, lauromacrogol may have an advantage over ethanol for its anesthetic effect of relieving pain during and after surgery.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research
Conclusions: Domperidone may be a safe and effective therapeutic modality to achieve a lasting remission of symptoms in children with AP-FGIDs.
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Clinical Trials: Gastroenterology Source Type: research
No abstract available
Source: Journal of Pediatric Gastroenterology and Nutrition - Category: Gastroenterology Tags: Case Reports Source Type: research
ConclusionMen living with metastatic prostate cancer have unique needs regarding physical activity related to symptoms of both their cancer and cancer treatment. There is a need to increase prompts that encourage those with metastatic prostate cancer to maintain/increase physical activity levels post diagnosis. Given the individualised needs of this patient group, referral to a cancer exercise specialist should be considered for prescription of tailored physical activity programmes.Trial registrationClinicaltrials.gov NLM Identifier: NCT02453139
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
ConclusionsTo our best knowledge, this is the first theory-driven study that investigates FCR experiences among Chinese American breast cancer survivors. Our study might provide a more comprehensive  understanding of FCR as it simultaneously shows predictors and a psychological consequence of FCR. Results need to be replicated in large, racially/ethnically diverse samples and longitudinal studies.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
AbstractBackgroundNeurolytic celiac plexus block (NCPB) is a safe and effective method for reducing abdominal cancer pain. However, the analgesic efficacy of NCPB is not always guaranteed. The aim of this retrospective study was to identify predictors for the analgesic efficacy of NCPB in patients with unresectable pancreatic cancer.MethodsPatients with unresectable pancreatic cancer who underwent NCPB from 2006 to 2015 were enrolled. Good analgesia after NCPB was defined as ≥ 50% reduction in pain score at day 30. Patient demographics, cancer characteristics, and pain-related factors were evaluated using a logis...
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Anesthesia | Anesthesiology | Boys | Children | Endoscopy | ENT & OMF | Girls | Hospitals | India Health | Pain | Pain Management | Study